Deliberate Compensated Vasoplegia–A Novel Pharmaceutical Approach for Controlling Blood Pressure During Surgery for Pheochromocytoma

[1]  M. Elston,et al.  Systematic Review: Incidence of Pheochromocytoma and Paraganglioma Over 70 Years , 2022, Journal of the Endocrine Society.

[2]  D. Thijssen,et al.  REGULATION OF CEREBRAL BLOOD FLOW IN HUMANS: PHYSIOLOGY AND CLINICAL IMPLICATIONS OF AUTOREGULATION. , 2021, Physiological reviews.

[3]  J. Phay,et al.  Update on Pheochromocytoma and Paraganglioma from the SSO Endocrine and Head and Neck Disease Site Working Group, Part 2 of 2: Perioperative Management and Outcomes of Pheochromocytoma and Paraganglioma , 2020, Annals of Surgical Oncology.

[4]  F. Sebag,et al.  Pheochromocytoma surgery without systematic preoperative pharmacological preparation: insights from a referral tertiary center experience , 2020, Surgical Endoscopy.

[5]  M. Behrends,et al.  International multicentre review of perioperative management and outcome for catecholamine‐producing tumours , 2020, The British journal of surgery.

[6]  M. Diener,et al.  Meta‐analysis of α‐blockade versus no blockade before adrenalectomy for phaeochromocytoma , 2020, The British journal of surgery.

[7]  K. Pacak,et al.  Postoperative Management in Patients with Pheochromocytoma and Paraganglioma , 2019, Cancers.

[8]  Paul Lee,et al.  Preoperative alpha‐blockade in phaeochromocytoma and paraganglioma: is it always necessary? , 2017, Clinical endocrinology.

[9]  R. Casey,et al.  Is there an optimal preoperative management strategy for phaeochromocytoma/paraganglioma? , 2017, Clinical endocrinology.

[10]  D. Schroeder,et al.  Preoperative Levels of Catecholamines and Metanephrines and Intraoperative Hemodynamics of Patients Undergoing Pheochromocytoma and Paraganglioma Resection. , 2017, Urology.

[11]  David F. Schneider,et al.  Selective Versus Non-selective α-Blockade Prior to Laparoscopic Adrenalectomy for Pheochromocytoma , 2016, Annals of Surgical Oncology.

[12]  W. Young,et al.  Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline. , 2014, The Journal of clinical endocrinology and metabolism.

[13]  Herb Chen,et al.  Safety and feasibility of laparoscopic resection for large (≥ 6 CM) pheochromocytomas without suspected malignancy. , 2012, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[14]  J. Augoustides,et al.  Perioperative management of pheochromocytoma: focus on magnesium, clevidipine, and vasopressin. , 2012, Journal of cardiothoracic and vascular anesthesia.

[15]  M. Warner,et al.  Perioperative management of pheochromocytoma. , 2002, Journal of cardiothoracic and vascular anesthesia.

[16]  K. Lam,et al.  Adrenal pheochromocytoma remains a frequently overlooked diagnosis. , 2000, American journal of surgery.

[17]  T. Ebert,et al.  Desflurane‐mediated Sympathetic Activation Occurs in Humans Despite Preventing Hypotension and Baroreceptor Unloading , 1998, Anesthesiology.

[18]  P. Fenster,et al.  Cardiovascular Effects of Sevoflurane Compared with Those of Isoflurane in Volunteers , 1995, Anesthesiology.

[19]  K. Rahn.  How should we treat a hypertensive emergency? , 1989, The American journal of cardiology.

[20]  M. Roizen,et al.  Anesthesia for patients with pheochromocytoma , 1987 .

[21]  E. Eger,et al.  A PROSPECTIVE RANDOMIZED TRIAL OF FOUR ANESTHETIC TECHNIQUES FOR RESECTION OF PHEOCHROMOCYTOMA , 1982 .

[22]  N. Lassen,et al.  Cerebral blood flow and oxygen consumption in man. , 1959, Physiological reviews.